N. A. Nakouzi

Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models.

Evgenia V. Dueva, M. Gleave, A. Zoubeidi, 2019, The Journal of clinical investigation.

Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth

C. Collins, M. Gleave, A. Wyatt, 2015, Clinical Cancer Research.

Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide Resistant Prostate Cancer Cell Growth Translational Relevance

A. Wyatt, A. Zoubeidi, L. Fazli, 2022 .

Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation

R. Young, P. Rennie, Kriti Singh, 2016, Molecular Cancer Therapeutics.

Abstract 3386: Mechanisms of resistance to enzalutamide in LNCaP models.

M. Gleave, A. Wyatt, A. Zoubeidi, 2013 .